Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02180841 · ClinicalTrials.gov registry record · NA
Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02180841: Completed NA study, sponsored by Penn State University.
NCT02180841 is a NA study that has completed, run by Penn State University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02180841, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the proposed pilot study is to evaluate the effects of a soy protein isolate with naturally occurring isoflavones on the properties of HDL-C (total HDL-C, HDL particle size and HDL function), central blood pressure, and indices of arterial stiffness.
Primary Outcome
Prior to start of intervention
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Soy Protein Powder (25g/d)
- DIETARY_SUPPLEMENT Soy Protein Powder (50g/d)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02180841 record still lists
NCT02180841 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02180841 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02180841 about?
NCT02180841 is a clinical study titled "Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness". The purpose of the proposed pilot study is to evaluate the effects of a soy protein isolate with naturally occurring isoflavones on the properties of HDL-C (total HDL-C, HDL particle size and HDL function), central blood pressure, and indices of arterial stiffness.
What is the current status of trial NCT02180841?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-03. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02180841?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Soy Protein Powder (25g/d) (DIETARY_SUPPLEMENT), Soy Protein Powder (50g/d) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02180841?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02180841's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia